The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Exelixis
Mayo Clinic
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Ohio State University
ViroMissile, Inc.
Hoffmann-La Roche
Seagen Inc.
Essen Biotech
DualityBio Inc.
MacroGenics
Jiangsu Simcere Pharmaceutical Co., Ltd.
Zhejiang University
Wondercel Biotech (ShenZhen)
Dysplasia Diagnostics Limited
Elephas
Mayo Clinic
Mayo Clinic
GV20 Therapeutics
West China Hospital
DualityBio Inc.
National Institutes of Health Clinical Center (CC)
University of Pittsburgh
Massive Bio, Inc.
7 Hills Pharma, LLC
Travera Inc
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Shanghai Public Health Clinical Center
3D Medicines
HC Biopharma Inc.
Aptamer Sciences, Inc.
Cofactor Genomics, Inc.
Sichuan University
National University Hospital, Singapore
Second Affiliated Hospital of Guangzhou Medical University
Second Affiliated Hospital of Guangzhou Medical University
BioEclipse Therapeutics